Company record
Provider of pharmaceutical development and commercialization services for specialty product formulations. Work includes formulation optimization, regulatory pathway development (505(b)(2)), and lifecycle management of branded and generic products. Active in therapeutic areas such as neurology, epilepsy, and rare disease treatments. Company markets and distributes drug products under U.S. regulatory approval.
This directory record does not yet have a linked material-flow brief.